Kaouthar Lbiati, MD
Vice President, Corporate Strategy
For over a decade, Dr. Lbiati served in leadership roles of increasing responsibilities at several of the world's leading pharmaceutical and biotechnology organizations: Amgen, Glaxo Smith Kline (GSK), Sanofi, and AstraZeneca. Most recently, she also advised a nasdaq-listed company ahead of a planned spin-off of its oncology activities, and helped a private oncology company repurpose their portfolio strategy across new indications.
Dr. Lbiati moved across different functions; Global Medical affairs, Health Economic Outcome Research, Reimbursement & Market Access, Strategy and Alliance management. Her work has spanned different countries (France, United Arab Emirates/Dubai, the United Kingdom, and the United States).
Since May 2020, She serves as scientific and strategy advisor at Cytovia therapeutics and in August 2020, she joined the company as Vice President product strategy.
Dr. Lbiati earned a Doctorate of Medicine (MD) from Mohammed V University in Morocco in 2006 and a post-graduate degree in oncology from Paris XI University coupled with a fellowship at the international Paris-based Institute Gustave Roussy (IGR). In 2009, she obtained a Specialized Executive Master’s degree in Strategy & Management from ESSEC Business School in France followed by a Master’s of science in International Policy and Health Economics from the London School of Economics (LSE) in 2016.